UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 83

Sortiert nach

Biweekly high-dose gemcitabine alone or in combination with capecitabine in patients with metastatic pancreatic adenocarcinoma: a randomized phase II trial

Annals of oncology, 2003-01, Vol.14 (1), p.97-104

2003

Link zum Volltext

Verfügbarkeit prüfen

Mitomycin C in combination with capecitabine or biweekly high-dose gemcitabine in patients with advanced biliary tract cancer: a randomised phase II trial

Annals of oncology, 2004-03, Vol.15 (3), p.478-483

2004

Link zum Volltext

Verfügbarkeit prüfen

Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancer

Annals of oncology, 2001-02, Vol.12 (2), p.183-186

2001

Link zum Volltext

Verfügbarkeit prüfen

Side effects during chemotherapy predict tumour response in advanced colorectal cancer

British journal of cancer, 2005-10, Vol.93 (7), p.744-748

2005

Link zum Volltext

Verfügbarkeit prüfen

Irinotecan plus raltitrexed vs raltitrexed alone in patients with gemcitabine-pretreated advanced pancreatic adenocarcinoma

British journal of cancer, 2003-04, Vol.88 (8), p.1180-1184

2003

Link zum Volltext

Verfügbarkeit prüfen

Effective treatment of oxaliplatin-induced cumulative polyneuropathy with alpha-lipoic acid

Journal of clinical oncology, 2002-08, Vol.20 (15), p.3359-3361

2002

Link zum Volltext

Verfügbarkeit prüfen

Subcutaneous administration of amifostine: A promising therapeutic option in patients with oxaliplatin-related peripheral sensitive neuropathy

Annals of oncology, 2001-03, Vol.12 (3), p.421-422

2001

Link zum Volltext

Verfügbarkeit prüfen

Amelioration of docetaxel/cisplatin induced polyneuropathy by α-lipoic acid

Annals of oncology, 2003-02, Vol.14 (2), p.339-340

2003

Link zum Volltext

Verfügbarkeit prüfen

Two Consecutive Phase II Studies of 5-Fluorouracil/Leucovorin/Mitomycin C and of Gemcitabine in Patients with Advanced Biliary Cancer

Oncology, 1999-04, Vol.56 (3), p.177-180

1999

Link zum Volltext

Verfügbarkeit prüfen

Intermittent weekly high-dose capecitabine in combination with oxaliplatin: a phase I/II study in first-line treatment of patients with advanced colorectal cancer

Annals of oncology, 2002-10, Vol.13 (10), p.1583-1589

2002

Link zum Volltext

Verfügbarkeit prüfen

Treatment of hepatocellular cancer with the long acting somatostatin analog lanreotide in vitro and in vivo

International journal of oncology, 2000-06, Vol.16 (6), p.1197

2000

Link zum Volltext

Verfügbarkeit prüfen

Effective combination chemotherapy with paclitaxel and cisplatin with or without human granulocyte colony-stimulating factor and or erythropoietin in patients with advanced gastric cancer

British journal of cancer, 2002-06, Vol.86 (12), p.1858-1863

2002

Link zum Volltext

Verfügbarkeit prüfen

Second-line treatment with oxaliplatin + raltitrexed in patients with advanced colorectal cancer failing fluoropyrimidine/leucovorin-based chemotherapy

Annals of oncology, 2001-05, Vol.12 (5), p.709-714

2001

Link zum Volltext

Verfügbarkeit prüfen

Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx

International journal of radiation oncology, biology, physics, 2001-07, Vol.50 (3), p.705-715

2001

Link zum Volltext

Verfügbarkeit prüfen

Multicenter phase II trial of dose-fractionated irinotecan in patients with advanced colorectal cancer failing oxaliplatin-based first-line combination chemotherapy

Annals of oncology, 2001-09, Vol.12 (9), p.1269-1272

2001

Link zum Volltext

Verfügbarkeit prüfen

Phase II trial of gemcitabine, epirubicin and granulocyte colony-stimulating factor in patients with advanced pancreatic adenocarcinoma

British Journal of Cancer, 1999-08, Vol.80 (11), p.1797-1802

1999

Link zum Volltext

Verfügbarkeit prüfen

Treatment of Advanced Breast Cancer with Vinorelbine and Docetaxel With or Without Human Granulocyte Colony-Stimulating Factor

Journal of clinical oncology, 2001-02, Vol.19 (3), p.621-627

2001

Link zum Volltext

Verfügbarkeit prüfen

Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil, leucovorin and cisplatin

British journal of cancer, 2000-01, Vol.82 (1), p.98-103

2000

Link zum Volltext

Verfügbarkeit prüfen

Idiosyncratic reaction after oxaliplatin: Circumvention by use of a continuous infusional administration schedule

Annals of oncology, 2001-11, Vol.12 (11), p.1653-1654

2001

Link zum Volltext

Verfügbarkeit prüfen

Phase II Study with Docetaxel and Cisplatin in the Treatment of Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck

Oncology, 2002-01, Vol.63 (2), p.145-150

2002

Link zum Volltext

Verfügbarkeit prüfen

Treatment of patients with advanced nonsmall cell lung carcinoma using docetaxel and gemcitabine plus granulocyte‐colony stimulating factor

Cancer, 2000-08, Vol.89 (3), p.516-522

2000

Link zum Volltext

Verfügbarkeit prüfen

Absence of therapeutic efficacy of the somatostatin analogue lanreotide in advanced primary hepatic cholangiocellular cancer and adenocarcinoma of the gallbladder despite in vivo somatostatin-receptor expression

Scandinavian journal of gastroenterology, 2002-02, Vol.37 (2), p.222-225

2002

Link zum Volltext

Verfügbarkeit prüfen

Treatment of advanced breast cancer with gemcitabine and vinorelbine plus human granulocyte colony-stimulating factor

Breast cancer research and treatment, 1999-06, Vol.55 (3), p.203-211

1999

Link zum Volltext

Verfügbarkeit prüfen

Capecitabine as salvage therapy for a breast cancer patient with extensive liver metastases and associated impairment of liver function

Onkologie, 2003-12, Vol.26 (6), p.578

2003

Link zum Volltext

Verfügbarkeit prüfen

Reinduction therapy with the same cytostatic regimen in patients with advanced colorectal cancer

British journal of cancer, 1998-09, Vol.78 (6), p.760-764

1998

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 83

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(77)
Mit Volltextzugriff
(74)

Publikationsform

Artikel
(83)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(74)
Life Sciences & Biomedicine
(68)
Science & Technology
(68)
Female
(59)
Oncology
(59)
Middle Aged
(57)
Aged
(55)
Male
(54)
Biological And Medical Sciences
(50)
Medical Sciences
(50)
Adult
(49)
Chemotherapy
(40)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(38)
Pharmacology. Drug Treatments
(36)
Antineoplastic Agents
(31)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(27)
Treatment Outcome
(22)
Deoxycytidine - Analogs & Derivatives
(18)
Adenocarcinoma - Drug Therapy
(17)
Colorectal Neoplasms - Drug Therapy
(16)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Biweekly high-dose gemcitabine alone or in combination with capecitabine in patients with metastatic pancreatic adenocarcinoma: a randomized phase II trial

Mitomycin C in combination with capecitabine or biweekly high-dose gemcitabine in patients with advanced biliary tract cancer: a randomised phase II trial

Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancer

Side effects during chemotherapy predict tumour response in advanced colorectal cancer

Irinotecan plus raltitrexed vs raltitrexed alone in patients with gemcitabine-pretreated advanced pancreatic adenocarcinoma

Effective treatment of oxaliplatin-induced cumulative polyneuropathy with alpha-lipoic acid

Subcutaneous administration of amifostine: A promising therapeutic option in patients with oxaliplatin-related peripheral sensitive neuropathy

Amelioration of docetaxel/cisplatin induced polyneuropathy by α-lipoic acid

Two Consecutive Phase II Studies of 5-Fluorouracil/Leucovorin/Mitomycin C and of Gemcitabine in Patients with Advanced Biliary Cancer

Intermittent weekly high-dose capecitabine in combination with oxaliplatin: a phase I/II study in first-line treatment of patients with advanced colorectal cancer

Treatment of hepatocellular cancer with the long acting somatostatin analog lanreotide in vitro and in vivo

Effective combination chemotherapy with paclitaxel and cisplatin with or without human granulocyte colony-stimulating factor and or erythropoietin in patients with advanced gastric cancer

Second-line treatment with oxaliplatin + raltitrexed in patients with advanced colorectal cancer failing fluoropyrimidine/leucovorin-based chemotherapy

Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx

Multicenter phase II trial of dose-fractionated irinotecan in patients with advanced colorectal cancer failing oxaliplatin-based first-line combination chemotherapy

Phase II trial of gemcitabine, epirubicin and granulocyte colony-stimulating factor in patients with advanced pancreatic adenocarcinoma

Treatment of Advanced Breast Cancer with Vinorelbine and Docetaxel With or Without Human Granulocyte Colony-Stimulating Factor

Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil, leucovorin and cisplatin

Idiosyncratic reaction after oxaliplatin: Circumvention by use of a continuous infusional administration schedule

Phase II Study with Docetaxel and Cisplatin in the Treatment of Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck

Treatment of patients with advanced nonsmall cell lung carcinoma using docetaxel and gemcitabine plus granulocyte‐colony stimulating factor

Absence of therapeutic efficacy of the somatostatin analogue lanreotide in advanced primary hepatic cholangiocellular cancer and adenocarcinoma of the gallbladder despite in vivo somatostatin-receptor expression

Treatment of advanced breast cancer with gemcitabine and vinorelbine plus human granulocyte colony-stimulating factor

Capecitabine as salvage therapy for a breast cancer patient with extensive liver metastases and associated impairment of liver function

Reinduction therapy with the same cytostatic regimen in patients with advanced colorectal cancer

Suchergebnisse filtern